@article{ref1,
title="Erratum: Vol. 71, No. 13. "Notes from the Field: Xylazine-Related Deaths -- Cook County, Illinois, 2017-2021"",
journal="MMWR: Morbidity and mortality weekly report",
year="2022",
author="The editors, ",
volume="71",
number="18",
pages="641-641",
abstract="In the report &quot;Notes from the Field: Xylazine-Related Deaths -- Cook County, Illinois, 2017-2021&quot; on page 503, the second paragraph of the second column should have read, &quot;A total of 210 xylazine-associated deaths were reported during the study period. Xylazine-associated deaths increased throughout the study period; incidence peaked during October 2021 (Figure). The percentage of fentanyl-associated deaths involving xylazine also increased throughout the study period, rising to a peak of 12.2% of fentanyl-related deaths assessed by the Cook County Medical Examiner's Office during October 2021. Fentanyl or fentanyl analogs were detected on forensic testing in most xylazine-involved deaths (99.1%). Other common co-occurring substances included diphenhydramine (78.1%), cocaine (41.9%), and quinine (33.8%). Naloxone was detected in 33.3% of xylazine-associated deaths.&quot;  The figure on page 503 was updated accordingly.<p /> <p>Language: en</p>",
language="en",
issn="0149-2195",
doi="10.15585/mmwr.mm7118a5",
url="http://dx.doi.org/10.15585/mmwr.mm7118a5"
}